Skip to main content
SpringerLink
Log in
Book cover

Recurrent Implantation Failure pp 153–174Cite as

Anatomic Abnormalities and Recurrent Implantation Failure

  • Chapter
  • First Online:

  • 587 Accesses

Abstract

Intrauterine abnormalities such as myomas, polyps, adhesions, and congenital septa have been shown to adversely affect embryo implantation and pregnancy outcomes. Treating these conditions improves pregnancy rates and outcomes. Hydrosalpinges reduce IVF pregnancy rates by ~50% by impeding embryo implantation. Treating them prior to IVF by salpingectomy, salpingostomy, or tubal ligation restores the success rates back to normal. This chapter reviews the pathophysiology of these abnormalities, therapeutic options, and treatment results.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Marshall LM, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol. 1997;90:967–73.

    Article  CAS  PubMed  Google Scholar 

  2. Munro MG, Critchley HOD, Fraser IS. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril. 2011;95:2204–8, 2208.e1–3

    Article  PubMed  Google Scholar 

  3. Munro MG. Abnormal uterine bleeding. Cambridge: Cambridge University Press; 2010.

    Google Scholar 

  4. Munro MG, Critchley HOD, Broder MS, Fraser IS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113:3–13.

    Article  PubMed  Google Scholar 

  5. Mehine M, et al. Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med. 2013;369:43–53.

    Article  CAS  PubMed  Google Scholar 

  6. Mäkinen N, et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011;334:252–5.

    Article  PubMed  CAS  Google Scholar 

  7. Dou Q, et al. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab. 1996;81:3222–30.

    CAS  PubMed  Google Scholar 

  8. Mas A, et al. Stro-1/CD44 as putative human myometrial and fibroid stem cell markers. Fertil Steril. 2015;104:225–34.e3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol. 2008;198:357–66.

    Article  PubMed  Google Scholar 

  10. Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril. 2009;91:1215–23.

    Article  PubMed  Google Scholar 

  11. Somigliana E, et al. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update. 2007;13:465–76.

    Article  CAS  PubMed  Google Scholar 

  12. Check JH, Choe JK, Lee G, Dietterich C. The effect on IVF outcome of small intramural fibroids not compressing the uterine cavity as determined by a prospective matched control study. Hum Reprod. 2002;17:1244–8.

    Article  CAS  PubMed  Google Scholar 

  13. Surrey ES, Lietz AK, Schoolcraft WB. Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome. Fertil Steril. 2001;75:405–10.

    Article  CAS  PubMed  Google Scholar 

  14. Benecke C, Kruger TF, Siebert TI, Van der Merwe JP, Steyn DW. Effect of fibroids on fertility in patients undergoing assisted reproduction. A structured literature review. Gynecol Obstet Investig. 2005;59:225–30.

    Article  CAS  Google Scholar 

  15. Brady PC, Stanic AK, Styer AK. Uterine fibroids and subfertility: an update on the role of myomectomy. Curr Opin Obstet Gynecol. 2013;25:255–9.

    Article  PubMed  Google Scholar 

  16. Practice Committee of American Society for Reproductive Medicine in Collaboration with Society of Reproductive Surgeons. Myomas and reproductive function. Fertil Steril. 2008;90:S125–30.

    Google Scholar 

  17. Yoshino O, et al. Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids. Hum Reprod. 2010;25:2475–9.

    Article  CAS  PubMed  Google Scholar 

  18. Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate? Hum Reprod. 2002;17:1424–30.

    Article  CAS  PubMed  Google Scholar 

  19. Hunt JE, Wallach EE. Uterine factors in infertility–an overview. Clin Obstet Gynecol. 1974;17:44–64.

    Article  CAS  PubMed  Google Scholar 

  20. Vollenhoven BJ, Lawrence AS, Healy DL. Uterine fibroids: a clinical review. Br J Obstet Gynaecol. 1990;97:285–98.

    Article  CAS  PubMed  Google Scholar 

  21. Ingersoll FM. Fertility following myomectomy. Fertil Steril. 1963;14:596–602.

    Article  CAS  PubMed  Google Scholar 

  22. Yoshino O, et al. Myomectomy decreases abnormal uterine peristalsis and increases pregnancy rate. J Minim Invasive Gynecol. 2012;19:63–7.

    Article  PubMed  Google Scholar 

  23. Deligdish L, Loewenthal M. Endometrial changes associated with myomata of the uterus. J Clin Pathol. 1970;23:676–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Rackow BW, Taylor HS. Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity. Fertil Steril. 2010;93:2027–34.

    Article  CAS  PubMed  Google Scholar 

  25. Buttram VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36:433–45.

    Article  PubMed  Google Scholar 

  26. Farrer-Brown G, Beilby JO, Tarbit MH. Venous changes in the endometrium of myomatous uteri. Obstet Gynecol. 1971;38:743–51.

    CAS  PubMed  Google Scholar 

  27. Farrer-Brown G, Beilby JO, Tarbit MH. The vascular patterns in myomatous uteri. J Obstet Gynaecol Br Commonw. 1970;77:967–75.

    Article  CAS  PubMed  Google Scholar 

  28. Donnez J, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med. 2012;366:421–32.

    Article  CAS  PubMed  Google Scholar 

  29. Stovall TG, Muneyyirci-Delale O, Summitt RL, Scialli AR. GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. Leuprolide Acetate Study Group. Obstet Gynecol. 1995;86:65–71.

    Article  CAS  PubMed  Google Scholar 

  30. Britten JL, et al. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production. Fertil Steril. 2012;98:1299–307.

    Article  CAS  PubMed  Google Scholar 

  31. Malik M, et al. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones. Fertil Steril. 2016;105:214–24.

    Article  CAS  PubMed  Google Scholar 

  32. Watanabe Y, et al. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women. Fertil Steril. 1992;58:66–71.

    Article  CAS  PubMed  Google Scholar 

  33. Friedman AJ, Hoffman DI, Comite F, Browneller RW, Miller JD. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group. Obstet Gynecol. 1991;77:720–5.

    CAS  PubMed  Google Scholar 

  34. Cirkel U, et al. Experience with leuprorelin acetate depot in the treatment of fibroids: a German multicentre study. Clin Ther. 1992;14(Suppl A):37–50.

    PubMed  Google Scholar 

  35. Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2001;2:CD000547. https://doi.org/10.1002/14651858.CD000547.

    Google Scholar 

  36. Trefoux Bourdet A, Luton D, Koskas M. Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence. Int J Womens Health. 2015;7:321–30.

    PubMed  PubMed Central  Google Scholar 

  37. Coddington CC, et al. Short term treatment with leuprolide acetate is a successful adjunct to surgical therapy of leiomyomas of the uterus. Surg Gynecol Obstet. 1992;175:57–63.

    CAS  PubMed  Google Scholar 

  38. Donnez J, Donnez O, Dolmans M-M. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice? Fertil Steril. 2014;102:640–8.

    Article  PubMed  Google Scholar 

  39. Kalampokas T, Kamath M, Boutas I, Kalampokas E. Ulipristal acetate for uterine fibroids: a systematic review and meta-analysis. Gynecol Endocrinol. 2016;32:91–6.

    Article  PubMed  Google Scholar 

  40. Donnez J, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012;366:409–20.

    Article  CAS  PubMed  Google Scholar 

  41. Chwalisz K, et al. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr Rev. 2005;26:423–38.

    Article  CAS  PubMed  Google Scholar 

  42. Maruo T, et al. Effects of progesterone on growth factor expression in human uterine leiomyoma. Steroids. 2003;68:817–24.

    Article  CAS  PubMed  Google Scholar 

  43. Luyckx M, et al. First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids. Fertil Steril. 2014;102:1404–9.

    Article  CAS  PubMed  Google Scholar 

  44. Luyckx M, et al. Long-term nonsurgical control with ulipristal acetate of multiple uterine fibroids, enabling pregnancy. Am J Obstet Gynecol. 2016;214(6):756.e1–2. https://doi.org/10.1016/j.ajog.2016.02.049.

    Article  CAS  Google Scholar 

  45. Ke L-Q, Yang K, Li J, Li C-M. Danazol for uterine fibroids. Cochrane Database Syst Rev. 2009;3:CD007692. https://doi.org/10.1002/14651858.CD007692.pub2.

    Google Scholar 

  46. Unlu C, Celik O, Celik N, Otlu B. Expression of endometrial receptivity genes increase after myomectomy of intramural leiomyomas not distorting the endometrial cavity. Reprod Sci. 2016;23:31–41.

    Article  CAS  PubMed  Google Scholar 

  47. Casini ML, Rossi F, Agostini R, Unfer V. Effects of the position of fibroids on fertility. Gynecol Endocrinol. 2006;22:106–9.

    Article  PubMed  Google Scholar 

  48. Carranza-Mamane B, et al. The management of uterine fibroids in women with otherwise unexplained infertility. J Obstet Gynaecol Can. 2015;37:277–88.

    Article  PubMed  Google Scholar 

  49. Dessolle L, et al. Determinants of pregnancy rate and obstetric outcome after laparoscopic myomectomy for infertility. Fertil Steril. 2001;76:370–4.

    Article  CAS  PubMed  Google Scholar 

  50. Bulletti C, De Ziegler D, Polli V, Flamigni C. The role of leiomyomas in infertility. J Am Assoc Gynecol Laparosc. 1999;6:441–5.

    Article  CAS  PubMed  Google Scholar 

  51. Metwally M, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev. 2012;11:CD003857.

    PubMed  Google Scholar 

  52. Seracchioli R, et al. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod. 2000;15:2663–8.

    Article  CAS  PubMed  Google Scholar 

  53. Palomba S, et al. A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: reproductive outcomes. Fertil Steril. 2007;88:933–41.

    Article  PubMed  Google Scholar 

  54. Thomas RL, Winkler N, Carr BR, Doody KM, Doody KJ. Abdominal myomectomy–a safe procedure in an ambulatory setting. Fertil Steril. 2010;94:2277–80.

    Article  PubMed  Google Scholar 

  55. Iavazzo C, Mamais I, Gkegkes ID. Robotic assisted vs laparoscopic and/or open myomectomy: systematic review and meta-analysis of the clinical evidence. Arch Gynecol Obstet. 2016;294:5–17.

    Article  PubMed  Google Scholar 

  56. van der Kooij SM, Bipat S, Hehenkamp WJK, Ankum WM, Reekers JA. Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and meta-analysis. Am J Obstet Gynecol. 2011;205:317.e1–18.

    Article  Google Scholar 

  57. Moss JG, et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG. 2011;118:936–44.

    Article  CAS  PubMed  Google Scholar 

  58. Jun F, et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta-analysis of the literature. Arch Gynecol Obstet. 2012;285:1407–13.

    Article  PubMed  Google Scholar 

  59. Ananthakrishnan G, et al. Randomized comparison of uterine artery embolization (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): subanalysis of 5-year MRI findings. Cardiovasc Intervent Radiol. 2013;36:676–81.

    Article  PubMed  Google Scholar 

  60. Torre A, et al. Uterine artery embolization for severe symptomatic fibroids: effects on fertility and symptoms. Hum Reprod. 2014;29:490–501.

    Article  CAS  PubMed  Google Scholar 

  61. Mara M, et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol. 2008;31:73–85.

    Article  PubMed  Google Scholar 

  62. Goldberg J, et al. Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol. 2004;191:18–21.

    Article  PubMed  Google Scholar 

  63. Berkane N, Moutafoff-Borie C. Impact of previous uterine artery embolization on fertility. Curr Opin Obstet Gynecol. 2010;22:242–7.

    Article  PubMed  Google Scholar 

  64. Hehenkamp WJK, et al. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod. 2007;22:1996–2005.

    Article  CAS  PubMed  Google Scholar 

  65. Clark NA, Mumford SL, Segars JH. Reproductive impact of MRI-guided focused ultrasound surgery for fibroids: a systematic review of the evidence. Curr Opin Obstet Gynecol. 2014;26:151–61.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Rabinovici J, et al. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril. 2010;93:199–209.

    Article  PubMed  Google Scholar 

  67. Berman JM, et al. Three-year outcome of the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas. J Minim Invasive Gynecol. 2014;21:767–74.

    Article  PubMed  Google Scholar 

  68. Brucker SY, et al. Laparoscopic radiofrequency volumetric thermal ablation of fibroids versus laparoscopic myomectomy. Int J Gynaecol Obstet. 2014;125:261–5.

    Article  PubMed  Google Scholar 

  69. Peterson WF, Novak ER. Endometrial polyps. Obstet Gynecol. 1956;8:40–9.

    CAS  PubMed  Google Scholar 

  70. Shokeir TA, Shalan HM, El-Shafei MM. Significance of endometrial polyps detected hysteroscopically in eumenorrheic infertile women. J Obstet Gynaecol Res. 2004;30:84–9.

    Article  PubMed  Google Scholar 

  71. Salim S, Won H, Nesbitt-Hawes E, Campbell N, Abbott J. Diagnosis and management of endometrial polyps: a critical review of the literature. J Minim Invasive Gynecol. 2011;18:569–81.

    Article  CAS  PubMed  Google Scholar 

  72. Hinckley MD, Milki AA. 1000 office-based hysteroscopies prior to in vitro fertilization: feasibility and findings. JSLS. 2004;8:103–7.

    PubMed  PubMed Central  Google Scholar 

  73. Fatemi HM, et al. Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to in vitro fertilization. Hum Reprod. 2010;25:1959–65.

    Article  CAS  PubMed  Google Scholar 

  74. Bozkurt M, Şahin L, Ulaş M. Hysteroscopic polypectomy decreases NF-κB1 expression in the mid-secretory endometrium of women with endometrial polyp. Eur J Obstet Gynecol Reprod Biol. 2015;189:96–100.

    Article  CAS  PubMed  Google Scholar 

  75. Pinheiro A, et al. Expression of hormone receptors, Bcl-2, Cox-2 and Ki67 in benign endometrial polyps and their association with obesity. Mol Med Rep. 2014;9:2335–41.

    Article  CAS  PubMed  Google Scholar 

  76. Hasegawa E, et al. Expression of leukemia inhibitory factor in the endometrium in abnormal uterine cavities during the implantation window. Fertil Steril. 2012;97:953–8.

    Article  CAS  PubMed  Google Scholar 

  77. Ben-Nagi J, Miell J, Yazbek J, Holland T, Jurkovic D. The effect of hysteroscopic polypectomy on the concentrations of endometrial implantation factors in uterine flushings. Reprod Biomed Online. 2009;19:737–44.

    Article  CAS  PubMed  Google Scholar 

  78. Bosteels J, et al. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst Rev. 2015;2:CD009461.

    Google Scholar 

  79. Pérez-Medina T, et al. Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomized study. Hum Reprod. 2005;20:1632–5.

    Article  PubMed  Google Scholar 

  80. Kodaman PH. Hysteroscopic polypectomy for women undergoing IVF treatment: when is it necessary? Curr Opin Obstet Gynecol. 2016;28(3):184–90. https://doi.org/10.1097/GCO.0000000000000277.

    Article  PubMed  Google Scholar 

  81. Pundir J, Pundir V, Omanwa K, Khalaf Y, El-Toukhy T. Hysteroscopy prior to the first IVF cycle: a systematic review and meta-analysis. Reprod Biomed Online. 2014;28:151–61.

    Article  PubMed  Google Scholar 

  82. Bosteels J, et al. Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility. Cochrane Database Syst Rev. 2015;11:CD011110.

    Google Scholar 

  83. Evans-Hoeker EA, Young SL. Endometrial receptivity and intrauterine adhesive disease. Semin Reprod Med. 2014;32:392–401.

    Article  PubMed  Google Scholar 

  84. Schenker JG, Margalioth EJ. Intrauterine adhesions: an updated appraisal. Fertil Steril. 1982;37:593–610.

    Article  CAS  PubMed  Google Scholar 

  85. Yu D, Wong Y-M, Cheong Y, Xia E, Li T-C. Asherman syndrome–one century later. Fertil Steril. 2008;89:759–79.

    Article  PubMed  Google Scholar 

  86. Wang X, Li Z, A YN, Zou S. Hysteroscopy for early abortion after IVF-ET: clinical analysis of 84 cases. Zhonghua Nan Ke Xue. 2011;17:52–4.

    PubMed  Google Scholar 

  87. Thomson AJM, Abbott JA, Deans R, Kingston A, Vancaillie TG. The management of intrauterine synechiae. Curr Opin Obstet Gynecol. 2009;21:335–41.

    Article  PubMed  Google Scholar 

  88. Deans R, Abbott J. Review of intrauterine adhesions. J Minim Invasive Gynecol. 2010;17:555–69.

    Article  PubMed  Google Scholar 

  89. Leung PL, Tam WH, Yuen PM. Hysteroscopic appearance of the endometrial cavity following thermal balloon endometrial ablation. Fertil Steril. 2003;79:1226–8.

    Article  PubMed  Google Scholar 

  90. Taskin O, et al. Long-term histopathologic and morphologic changes after thermal endometrial ablation. J Am Assoc Gynecol Laparosc. 2002;9:186–90.

    Article  PubMed  Google Scholar 

  91. Mukul LV, Linn JG. Pregnancy complicated by uterine synechiae after endometrial ablation. Obstet Gynecol. 2005;105:1179–82.

    Article  PubMed  Google Scholar 

  92. Schenker JG. Etiology of and therapeutic approach to synechia uteri. Eur J Obstet Gynecol Reprod Biol. 1996;65:109–13.

    Article  CAS  PubMed  Google Scholar 

  93. Foix A, et al. The pathology of postcurettage intrauterine adhesions. Am J Obstet Gynecol. 1966;96:1027–33.

    Article  CAS  PubMed  Google Scholar 

  94. Polishuk WZ, Anteby SO, Weinstein D. Puerperal endometritis and intrauterine adhesions. Int Surg. 1975;60:418–20.

    CAS  PubMed  Google Scholar 

  95. Valle RF, Sciarra JJ. Intrauterine adhesions: hysteroscopic diagnosis, classification, treatment, and reproductive outcome. Am J Obstet Gynecol. 1988;158:1459–70.

    Article  CAS  PubMed  Google Scholar 

  96. Katz Z, Ben-Arie A, Lurie S, Manor M, Insler V. Reproductive outcome following hysteroscopic adhesiolysis in Asherman’s syndrome. Int J Fertil Menopausal Stud. 1996;41:462–5.

    CAS  PubMed  Google Scholar 

  97. The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and intrauterine adhesions. Fertil Steril. 1988;49:944–55.

    Google Scholar 

  98. Saravelos SH, Cocksedge KA, Li T-C. Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal. Hum Reprod Update. 2008;14:415–29.

    Article  PubMed  Google Scholar 

  99. Patton PE. Anatomic uterine defects. Clin Obstet Gynecol. 1994;37:705–21.

    Article  CAS  PubMed  Google Scholar 

  100. Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update. 2001;7:161–74.

    Article  CAS  PubMed  Google Scholar 

  101. Homer HA, Li TC, Cooke ID. The septate uterus: a review of management and reproductive outcome. Fertil Steril. 2000;73:1–14.

    Article  CAS  PubMed  Google Scholar 

  102. Kupesic S. Clinical implications of sonographic detection of uterine anomalies for reproductive outcome. Ultrasound Obstet Gynecol. 2001;18:387–400.

    Article  CAS  PubMed  Google Scholar 

  103. Letterie G. Structural abnormalities and reproductive failure: effective techniques for diagnosis and management. New York: Blackwell Science; 1998.

    Google Scholar 

  104. Lavergne N, Aristizabal J, Zarka V, Erny R, Hedon B. Uterine anomalies and in vitro fertilization: what are the results? Eur J Obstet Gynecol Reprod Biol. 1996;68:29–34.

    Article  CAS  PubMed  Google Scholar 

  105. Heinonen PK, Saarikoski S, Pystynen P. Reproductive performance of women with uterine anomalies. An evaluation of 182 cases. Acta Obstet Gynecol Scand. 1982;61:157–62.

    Article  CAS  PubMed  Google Scholar 

  106. DeCherney AH, Russell JB, Graebe RA, Polan ML. Resectoscopic management of müllerian fusion defects. Fertil Steril. 1986;45:726–8.

    Article  CAS  PubMed  Google Scholar 

  107. Fayez JA. Comparison between abdominal and hysteroscopic metroplasty. Obstet Gynecol. 1986;68:399–403.

    Article  CAS  PubMed  Google Scholar 

  108. Devi Wold AS, Pham N, Arici A. Anatomic factors in recurrent pregnancy loss. Semin Reprod Med. 2006;24:25–32.

    Article  PubMed  Google Scholar 

  109. Propst AM, Hill JA. Anatomic factors associated with recurrent pregnancy loss. Semin Reprod Med. 2000;18:341–50.

    Article  CAS  PubMed  Google Scholar 

  110. Bailey AP, Jaslow CR, Kutteh WH. Minimally invasive surgical options for congenital and acquired uterine factors associated with recurrent pregnancy loss. Womens Health. 2015;11:161–7.

    CAS  Google Scholar 

  111. Chan YY, et al. Reproductive outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound Obstet Gynecol. 2011;38:371–82.

    Article  CAS  PubMed  Google Scholar 

  112. Fedele L, et al. Ultrastructural aspects of endometrium in infertile women with septate uterus. Fertil Steril. 1996;65:750–2.

    Article  CAS  PubMed  Google Scholar 

  113. Sparac V, Kupesic S, Ilijas M, Zodan T, Kurjak A. Histologic architecture and vascularization of hysteroscopically excised intrauterine septa. J Am Assoc Gynecol Laparosc. 2001;8:111–6.

    Article  CAS  PubMed  Google Scholar 

  114. Raga F, Casañ EM, Bonilla-Musoles F. Expression of vascular endothelial growth factor receptors in the endometrium of septate uterus. Fertil Steril. 2009;92:1085–90.

    Article  CAS  PubMed  Google Scholar 

  115. Taylor E, Gomel V. The uterus and fertility. Fertil Steril. 2008;89:1–16.

    Article  PubMed  Google Scholar 

  116. Mollo A, et al. Hysteroscopic resection of the septum improves the pregnancy rate of women with unexplained infertility: a prospective controlled trial. Fertil Steril. 2009;91:2628–31.

    Article  PubMed  Google Scholar 

  117. Venetis CA, et al. Clinical implications of congenital uterine anomalies: a meta-analysis of comparative studies. Reprod Biomed Online. 2014;29:665–83.

    Article  PubMed  Google Scholar 

  118. Kowalik CR, et al. Metroplasty versus expectant management for women with recurrent miscarriage and a septate uterus. Cochrane Database Syst Rev. 2011;6:CD008576. https://doi.org/10.1002/14651858.CD008576.pub3.

    Google Scholar 

  119. Raga F, et al. Reproductive impact of congenital Müllerian anomalies. Hum Reprod. 1997;12:2277–81.

    Article  CAS  PubMed  Google Scholar 

  120. Mucowski SJ, Herndon CN, Rosen MP. The arcuate uterine anomaly: a critical appraisal of its diagnostic and clinical relevance. Obstet Gynecol Surv. 2010;65:449–54.

    Article  PubMed  Google Scholar 

  121. Reichman D, Laufer MR, Robinson BK. Pregnancy outcomes in unicornuate uteri: a review. Fertil Steril. 2009;91:1886–94.

    Article  PubMed  Google Scholar 

  122. Buttram VC. Müllerian anomalies and their management. Fertil Steril. 1983;40:159–63.

    Article  PubMed  Google Scholar 

  123. Heinonen PK. Clinical implications of the didelphic uterus: long-term follow-up of 49 cases. Eur J Obstet Gynecol Reprod Biol. 2000;91:183–90.

    Article  CAS  PubMed  Google Scholar 

  124. Mashiach S, Ben-Rafael Z, Dor J, Serr DM. Triplet pregnancy in uterus didelphys with delivery interval of 72 days. Obstet Gynecol. 1981;58:519–21.

    CAS  PubMed  Google Scholar 

  125. Papp Z, Mezei G, Gávai M, Hupuczi P, Urbancsek J. Reproductive performance after transabdominal metroplasty: a review of 157 consecutive cases. J Reprod Med. 2006;51:544–52.

    PubMed  Google Scholar 

  126. Chu J, et al. Salpingostomy in the treatment of hydrosalpinx: a systematic review and meta-analysis. Hum Reprod. 2015;30:1882–95.

    Article  CAS  PubMed  Google Scholar 

  127. Bahamondes L, et al. Identification of main risk factors for tubal infertility. Fertil Steril. 1994;61:478–82.

    Article  CAS  PubMed  Google Scholar 

  128. Zeyneloglu HB, Arici A, Olive DL. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization-embryo transfer. Fertil Steril. 1998;70:492–9.

    Article  CAS  PubMed  Google Scholar 

  129. Camus E, et al. Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod. 1999;14:1243–9.

    Article  CAS  PubMed  Google Scholar 

  130. Mansour RT, Aboulghar MA, Serour GI, Riad R. Fluid accumulation of the uterine cavity before embryo transfer: a possible hindrance for implantation. J In Vitro Fert Embryo Transf. 1991;8:157–9.

    Article  CAS  PubMed  Google Scholar 

  131. Andersen AN, Lindhard A, Loft A, Ziebe S, Andersen CY. The infertile patient with hydrosalpinges–IVF with or without salpingectomy? Hum Reprod. 1996;11:2081–4.

    Article  CAS  PubMed  Google Scholar 

  132. Vandromme J, et al. Hydrosalpinges in in-vitro fertilization: an unfavourable prognostic feature. Hum Reprod. 1995;10:576–9.

    Article  CAS  PubMed  Google Scholar 

  133. Strandell A, Lindhard A. Why does hydrosalpinx reduce fertility? The importance of hydrosalpinx fluid. Hum Reprod. 2002;17(5):1141.

    Article  PubMed  Google Scholar 

  134. Jiang H, Pei H, Zhang W, Wang X. A prospective clinical study of interventional ultrasound sclerotherapy on women with hydrosalpinx before in vitro fertilization and embryo transfer. Fertil Steril. 2010;94:2854–6.

    Article  PubMed  Google Scholar 

  135. Li L, et al. Effects of hydrosalpinx on pinopodes, leukaemia inhibitory factor, integrin beta3 and MUC1 expression in the peri-implantation endometrium. Eur J Obstet Gynecol Reprod Biol. 2010;151:171–5.

    Article  CAS  PubMed  Google Scholar 

  136. Song Y, et al. NF κB expression increases and CFTR and MUC1 expression decreases in the endometrium of infertile patients with hydrosalpinx: a comparative study. Reprod Biol Endocrinol. 2012;10:86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  137. Daftary GS, et al. Salpingectomy increases peri-implantation endometrial HOXA10 expression in women with hydrosalpinx. Fertil Steril. 2007;87:367–72.

    Article  CAS  PubMed  Google Scholar 

  138. Seli E, et al. Removal of hydrosalpinges increases endometrial leukaemia inhibitory factor (LIF) expression at the time of the implantation window. Hum Reprod. 2005;20:3012–7.

    Article  CAS  PubMed  Google Scholar 

  139. Bildirici I, Bukulmez O, Ensari A, Yarali H, Gurgan T. A prospective evaluation of the effect of salpingectomy on endometrial receptivity in cases of women with communicating hydrosalpinges. Hum Reprod. 2001;16:2422–6.

    Article  CAS  PubMed  Google Scholar 

  140. Bedaiwy MA, et al. Relationship between oxidative stress and embryotoxicity of hydrosalpingeal fluid. Hum Reprod. 2002;17:601–4.

    Article  PubMed  Google Scholar 

  141. Bedaiwy MA, et al. Relationship between cytokines and the embryotoxicity of hydrosalpingeal fluid. J Assist Reprod Genet. 2005;22:161–5.

    Article  PubMed  PubMed Central  Google Scholar 

  142. Johnson N, van Voorst S, Sowter MC, Strandell A, Mol BWJ. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev. 2010;1:CD002125. https://doi.org/10.1002/14651858.CD002125.pub3.

    Google Scholar 

  143. Kontoravdis A, et al. Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx. Fertil Steril. 2006;86:1642–9.

    Article  PubMed  Google Scholar 

  144. Chanelles O, et al. Hydrosalpinx and infertility: what about conservative surgical management? Eur J Obstet Gynecol Reprod Biol. 2011;159:122–6.

    Article  PubMed  Google Scholar 

  145. Dreyer K, et al. Hysteroscopic proximal tubal occlusion versus laparoscopic salpingectomy as a treatment for hydrosalpinges prior to IVF or ICSI: an RCT. Hum Reprod. 2016. https://doi.org/10.1093/humrep/dew050.

  146. Hammadieh N, et al. Ultrasound-guided hydrosalpinx aspiration during oocyte collection improves pregnancy outcome in IVF: a randomized controlled trial. Hum Reprod. 2008;23:1113–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecology and Obstetrics, Cleveland Clinic, Cleveland, OH, USA

    Jeffrey M. Goldberg MD, Julian Gingold MD & Natalia Llarena MD

Authors
  1. Jeffrey M. Goldberg MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julian Gingold MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Natalia Llarena MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey M. Goldberg MD .

Editor information

Editors and Affiliations

  1. Reproductive Medicine Associates of NJ, Thomas Jefferson University, Basking Ridge, New Jersey, USA

    Jason M. Franasiak

  2. Reproductive Medicine Associates of NJ, Thomas Jefferson University, Basking Ridge, New Jersey, USA

    Richard T. Scott Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Goldberg, J.M., Gingold, J., Llarena, N. (2018). Anatomic Abnormalities and Recurrent Implantation Failure. In: Franasiak, J., Scott Jr., R. (eds) Recurrent Implantation Failure. Springer, Cham. https://doi.org/10.1007/978-3-319-71967-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-71967-2_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-71966-5

  • Online ISBN: 978-3-319-71967-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation